Abstract: Photodynamic therapy of conditions of the eye characterized by unwanted neovasculature, such as age-related macular degeneration, is effective using green porphyrins as photoactive agents, preferably as liposomal compositions.
Type:
Grant
Filed:
February 17, 1995
Date of Patent:
August 25, 1998
Assignees:
The General Hospital Corporation, Quadra Logic Technologies, Inc., Massachuesetts Eye & Ear Infirmary
Inventors:
Julia Levy, Joan W. Miller, Evangelos S. Gradoudas, Tayyaba Hasan, Ursula Schmidt-Erfurth